Sucralfate
- Product NDC
- 53002-4930
- 11-digit product format
- 530024930
- Labeler code
- 53002
- Product ID
- 53002-4930_71c82bd2-13c9-4a03-8b34-6f55ec7202a3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sucralfate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA070848
- Marketing category
- ANDA
- Marketing start
- 1996-11-11
- Marketing end
- 0000-00-00
- Substance
- SUCRALFATE
- Active strength
- 1 g/1
- Pharmacologic classes
- Aluminum Complex [EPC],Organometallic Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-4930-2 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-4 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-2 | 2023-06-07 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-4 | 2023-06-07 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-2 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-4 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-2 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-4 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
| 53002-4930-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2403-f424-e053-dadaa90a57ce | SUCRALFATE TABLETS, USP 2210 Rx only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-4930-2 | Sucralfate | 20 in 1 BOTTLE | TABLET | 20 | | 5 |
| 53002-4930-4 | Sucralfate | 40 in 1 BOTTLE | TABLET | 40 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-4930 | SUCRALFATE TABLET [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 2 package rows | 20230609_671ace12-dceb-4f50-9c20-807da7c12562.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-4930-2 | 53002493002 | 20 TABLET in 1 BOTTLE (53002-4930-2) | 20 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-4930-4 | 53002493004 | 40 TABLET in 1 BOTTLE (53002-4930-4) | 40 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |